A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT

We report a single-center phase I/II trial exploring the combination of everolimus (EVE) and mycophenolate mofetil (MMF) as calcineurin inhibitor (CNI)-free GVHD prophylaxis for 24 patients with hematologic malignancies and indication for allogeneic HCT after a high dose or reduced-intensity ablativ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Hematol
Main Authors: Schäfer, Henning, Blümel-Lehmann, Jacqueline, Ihorst, Gabriele, Bertz, Hartmut, Wäsch, Ralph, Zeiser, Robert, Finke, Jürgen, Marks, Reinhard
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285343/
https://ncbi.nlm.nih.gov/pubmed/33755792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-021-04487-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados